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Abstract
Introduction Diagnostic tools to show emboli reliably and
protection techniques against embolization when employing
stent retrievers are necessary to improve endovascular stroke
therapy. The aim of the present study was to investigate iatro-
genic emboli using susceptibility-weighted imaging (SWI) in
an open series of patients who had been treated with stent
retriever thrombectomy using emboli protection techniques.
Methods Patients with anterior circulation stroke examinedwith
MRI before and after stent retriever thrombectomy were
assessed for iatrogenic embolic events. Thrombectomy was per-
formed in flow arrest and under aspiration using a balloon-
mounted guiding catheter, a distal access catheter, or both.
Results In 13 of 57 patients (22.8 %) post-interventional SWI
sequences detected 16 microemboli. Three of them were as-
sociated with small ischemic lesions on diffusion-weighted
imaging (DWI). None of the microemboli were located in a
new vascular territory, none showed clinical signs, and all 13
patients have been rated as Thrombolysis in Cerebral
Infarction (TICI) 2b (n=3) or 3 (n=10). Retrospective reeval-
uation of the digital subtraction angiography (DSA) detected
discrete flow stagnation nearby the iatrogenic microemboli in
four patients with a positive persistent collateral sign in one.
Conclusion Our study demonstrates two things: First, SWI
seems to be more sensitive to detect emboli than DWI and
DSA and, second, proximal or distal protected stent retriever
thrombectomy seems to prevent iatrogenic embolization into
new vascular territories during retraction of the thrombus, but
not downstream during mobilization of the thrombus. Both
techniques should be investigated and refined further.
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Introduction
Mechanical thrombectomy provides higher recanalization
rates than intravenous or intraarterial thrombolysis, but clini-
cal outcome is highly variable even with successful revascu-
larization [1–14]. Good clinical outcome after mechanical
thrombectomy, using mainly or exclusively thrombus
fragmenting techniques and instruments (Penumbra trial,
Multi MERCI trial, IMS III, MR RESCUE, SYNTHESIS)
[6, 7, 15–17], is inferior even compared to studies using local
arterial thrombolysis (PROACT II, MELT) [9, 18] or
protected stent retriever thrombectomy (Dávalos et al.,
STAR trial, ESCAPE trial, EXTEND-IA trial, SWIFT-
Prime) [2, 3, 11, 12, 14]. This might be explained partially
by iatrogenic embolization into new vascular territories detect-
ed angiographically in 8.6 % of all patients in the ground-
breaking Multicenter Randomized Clinical Trial of
Endovascular Treatment for Acute Ischemic Stroke in the
Netherlands (MR CLEAN) study [1]. Thrombectomy devices
may fragment clots and create distal emboli that potentially
disrupt collateral blood supply to the penumbra and deterio-
rate clinical outcome [19]. Animal in vivo studies have shown
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that thrombectomy devices can disrupt clots in different ways
and cause variable rates of embolic events (EEs) [20]. To date,
diffusion-weighted imaging (DWI) [21] and digital subtrac-
tion angiography (DSA) [15, 16] are considered as the best
techniques for detection of emboli related to endovascular
procedures. In acute stroke, however, the initial DWI lesion
may mask secondary treatment-related emboli and DSA can-
not reliably differentiate between no reflow and new EE.
Moreover, only a minority of thrombus fragments can be de-
tected on the pre-interventional diagnostic DSA [22].
Therefore, DSA cannot differentiate between a pre-existing
thrombus fragment and an iatrogenic EE downstream the pri-
mary site of occlusion. In addition, still active collaterals can
inhibit the antegrade bloodflow downstream the recanalized
big vessel, especially if flow and pressure are diminished by
mechanically induced vasospasms or if the control DSA has
been performed with the 8- or 9-French guiding catheter
placed in the internal carotid artery. Therefore, stagnating flow
must not indicate distal emboli. Considering that the
Thrombolysis in Cerebral Infarction (TICI) classification is
normally based on a final selective one-vessel DSA, even a
reduced parenchymal blush can be caused by still active col-
laterals, feeding non-contrasted blood into the contrasted vas-
cular territory.
Susceptibility-weighted imaging (SWI), a relatively new
technique in the primary and follow-up MRI evaluation of
patients with acute stroke [23, 24], could probably overcome
these limitations through its ability to detect even small em-
boli. In a recent study, SWI detected the occluding thrombus
in 95 % of patients with stroke of the anterior circulation, and
the presence of primarily fragmented thrombi before initiation
of thrombolytic therapy predicted worse outcome [22].
The aims of the present study were to investigate the fre-
quency of iatrogenic EE following protected stent retriever
thrombectomy using SWI and to compare the results with
those obtained with DWI and DSA.
Methods
Patients and clinical data
Three hundred eighty-four consecutive acute ischemic stroke
patients treated with stent retriever thrombectomy at our
stroke unit, from January 2010 to December 2013, were
screened. Of these, 57 patients had acute ischemic stroke of
the anterior circulation and underwent pre- and post-
interventional MRI including DWI and SWI and were includ-
ed in this retrospective study. All patients had anterior circu-
lation strokes due to tandem occlusions of the internal carotid
artery (ICA) and middle cerebral artery (MCA), distal ICA
occlusions, carotid T occlusions, isolated occlusions of the
MCA (M1 or M2 segment), or multiple occlusions of the
anterior circulation (MCA in combination with anterior cere-
bral artery (ACA)).
Clinical data were recorded prospectively in our stroke reg-
istry. Cerebral reperfusion was assessed at the end of the
endovascular intervention, on biplane or 3D rotational angiog-
raphy, according to the TICI grading system [25]. The occur-
rence of symptomatic (sICH) and asymptomatic (aICH) intra-
cranial hemorrhage was recorded according to the PROACT II
criteria [18]. Clinical outcome was assessed 3 months after the
ictus with the modified Rankin Scale (mRS).
Imaging and treatment
Standard strokeMRI protocol was performed, which included
DWI, T2-weighted imaging, fluid-attenuated inversion recov-
ery (FLAIR), TOF magnetic resonance angiogram (MRA),
SWI, first-pass gadolinium-enhanced MRA of the cervical
and intracranial arteries, and perfusion imaging. The scans
were acquired with a 1.5- and 3-T MRI system (Magnetom
Avanto and Magnetom Verio; Siemens, Erlangen, Germany).
For the 1.5-T system, the SWI parameters were as follows:
repetition time (TR) 49 ms, echo time (TE) 40 ms, number of
averages 1, field of view (FoV) read 230 mm, FoV phase
75.0 %, voxel size 0.9×0.7×1.8 mm, flip angle 15°, and ac-
quisition time 2 min and 59 s. For the 3-T scanner, the param-
eters were as follows: TR 28 ms, TE 20 ms, number of aver-
ages 1, FoV read 230 mm, FoV phase 75.0 %, voxel size 0.9×
0.9×2.0 mm, flip angle 15°, and acquisition time 2:59min.
The SWI and minimum intensity projection (mIP) images
were generated automatically by the scanner software.
As described previously [2–4], stent retriever thrombectomy
was performed using a biplane, high-resolution angiographic
system (Axiom Artis zee; Siemens, Erlangen, Germany). To
reduce the risk of embolic complications, retrieval of the stent
was performed in flow arrest using a balloon-mounted guiding
catheter with its tip as close as possible to the skull base, to
prevent the ICA from collapsing during aspiration. In addition,
in patients with anatomically difficult access, a high-volume
distal access aspiration catheter was used, if the 8- or 9-Fg
balloon guiding catheter had to be inflated more proximally.
Imaging analysis
MRI and DSAwere evaluated retrospectively by two experi-
enced neuroradiologists and a radiologist in training. Pre-
interventional MRI was analyzed for the presence of a suscep-
tibility vessel sign, and thrombus length was measured on
SWI as described previously [22, 24].
Post-interventional SWI was analyzed for signs of EE. To
better discriminate emboli from vascular structures, additional
minimum intensity (mIP, Fig. 1) andmultiplanar (Figs. 2 and 3)
projections of the SWI were reformatted. Emboli were defined
as areas of tubular or dot-like signal drop not seen on pre-
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interventional SWI, following the direction of branches of the
middle, anterior, or posterior cerebral arteries (Figs. 1, 2, and 3).
Emboli were described as being located either inside or outside
of the infarcted tissue, defined on post-interventional DWI and
T2-weighted/FLAIR images.
Biplane and/or 3D DSA was routinely performed after
endovascular treatment and rated according to the TICI clas-
sification by the team of interventional neuroradiologists, who
had performed the endovascular therapy (Table 1). When ret-
rospectively reviewing the DWI and DSA, the raters were
aware of the results of the SWI. For this reevaluation, the
collaterals were identified in the pre-treatment DSA series,
which are stored completely in our PACS system. Four- or
at least three-vessel angiography (with opacification of the
basilar artery via the dominant vertebral artery) is a mandatory
part of our stroke protocol; thus, collaterals from the
vertebrobasilar system (Fig. 4) and the contralateral side could
be included in this evaluation. Re-examination of the post-
interventional control DSA focused on the dynamic flow pat-
tern of the arteries around the SWI-proven EE in at least two
planes. The results were compared to the pre-treatment
angioarchitecture, regarding if bloodflow of the collaterals
was antegrade, stagnating, or still reversed and if the paren-
chymal blush was diminished. Control DSA was normally
performed with the guiding catheter in the common carotid
artery and the balloon fully deflated. Thus, disturbances of the
flow could be avoided, and the flow pattern of the external
carotid artery was used to calibrate the DSA as an internal
quality control. Additional DSAs of the contralateral and pos-
terior circulation have been performed frequently, if the wa-
tershed territory was not fully opacified in the selective ipsi-
lateral DSA, and this information was also included in the
TICI classification of the neuroradiologist in charge of the
intervention (Table 1).
Statistical analysis
Successful reperfusion was defined as TICI grades 2b–3.
Clinical outcome was dichotomized into favorable (mRS
scores 0–2) and poor outcome (mRS scores 3–6). The associ-
ation of categorical variables with EE was analyzed with
Fisher’s exact test. Continuous and ordinal variables were
compared by Mann–Whitney U test. A probability value
<0.05 was considered significant. Statistics were performed
with SPSS Version 21 (IBM Corp., Armonk, NY).
Results
Occlusion characteristics and time point of imaging
Thirty-six patients had occlusions of the M1 segment, one of
them in combination with a thrombus in the ipsilateral A3
segment. Five patients had isolated M2 occlusions. Nine pa-
tients presented with tandem occlusions affecting the ICA and
ipsilateral MCA (M1 in eight patients, and M2 in one patient).
In six patients, a carotid T occlusion was found. One patient
had an occlusion of the distal ICA. Median NIH Stroke Scale
(NIHSS) score on admission was 14 (range, 2–36).
Pre-interventional MRI was obtained 3.0±2.3 h, and post-
interventional MRI 43.6±43.5 h after stroke onset. Median
time from symptom onset or in case of wake-up stroke time
last seen well, to initiation of endovascular intervention was
4.0±2.4 h.
Fig. 1 A 72-year-old man with
mild aphasia and right-sided
hemiparesis (NIHSS score 5).
MRI shows left proximal MCA
occlusion. On initial SWI,
prominent veins in the region of
the left Sylvian fissure are seen
(a [axial, mIP] and b [coronal]).
DWI shows diffusion restriction
in the basal ganglia (c). Post-
interventional SWI demonstrates
a punctate signal drop
corresponding to a peri-
interventional embolus (d [white
arrow, mIP] and e [black arrow]).
The embolus is located outside of
the infarcted area as seen on
post-interventional DWI (f)
Neuroradiology
Pre- and post-interventional imaging
Susceptibility vessel sign on pre-interventional SWI, corre-
sponding to the proximal occluding thrombus, was detected
in 56 of 57 patients (98.2 %). In one patient without suscep-
tibility vessel sign, MRA showed an ICA but no MCA occlu-
sion. Subsequent DSA demonstrated a tandem occlusion with
thrombus located in the proximal and distal ICA andM1, most
likely because of thrombus fragmentation and migration that
occurred during intravenous bridging thrombolysis after the
pre-interventional MRI and before start of the DSA.
Mean thrombus length, which could be measured on SWI
in 49 patients, was 12.9±7.1 mm. Fragmented thrombi on pre-
treatment SWI were seen in one patient with an MCA
thrombus and additional separate fragments in the M1 and
M2 segments (Fig. 2).
Imaging of new emboli and association with clinical
parameters
New embolic lesions were found in 13 of 57 patients (22.8 %).
Eleven patients had single emboli, one had two, and one three
emboli (Table 1). All emboli were located in the MCA terri-
tory downstream to the occluding thrombus. No emboli were
detected in the ACA and posterior cerebral artery territories.
Eleven emboli occurred in patients with occlusions of the
MCA, one with a tandem (ICA and M2), and one with a distal
ICA occlusion. The emboli were located outside of the infarct
Fig. 2 A 83-year-old man with right-sided hemiparesis (NIHSS score 21).
Two separate thrombi in the left proximal M1 segment and the MCA
bifurcation are seen on DSA (a, black arrows). Pre-interventional SWI
shows thrombotic material in the proximal M1 segment and MCA
bifurcation extending in an M2 branch (measuring 10 and 9 mm on
SWI; d, white arrowhead) but no additional distal fragments (e). Two
thrombus fragments were retrieved (c). Final biplane DSA control was
rated as TICI 3 reperfusion (b). Post-interventional SWI detected one EE
(f,white arrow) with an associated ischemic lesion onDWI (g). The sagittal
reformatted projection of the SWI confirms the extracerebral location of the
EE and its orientation along a suprasylvian MCA branch (h). Lateral DSA
shows stagnating flow in the corresponding MCA branch with discretely
diminished parenchymal blush during this phase of the DSA (i). (Artifacts
are produced by simultaneous recording of NIRS)
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core, defined by post-treatment DWI images, in nine patients
and inside in four. Mean length of the distally migrated
thrombus fragments on SWI was 5.2±1.2 mm (range, 3.6–
7.8 mm). Multiplanar reconstructions of the SWI images usu-
ally confirmed the ovoid shape of the EE, aligned to the
course of the sylvian and suprasylvian branches of the
MCA (Figs. 1, 2, and 3).
New ischemic lesions related to iatrogenic EE were detect-
ed on DWI in three patients (Figs. 2 and 3). Distal branch
occlusions were visible on final post-thrombectomy biplane
or 3D DSA in none of the patients with EE. Subsequently,
recanalization had been rated as TICI 2b (n=3) or TICI 3
(n=10) in the initial radiological report. Reperfusion in the
44 patients without EE has been rated as TICI 0, n=3; TICI
2a, n=5; TICI 2b, n=18; and TICI 3, n=18.
Retrospective reevaluation, focusing on the area where the
new EEs were localized on post-interventional SWI, detected
stagnating flow in four patients, with two of them showing
also newDWI lesions (Figs. 2 and 3). In one patient, persistent
collateral sign was found, which is defined as persistent retro-
grade flow in arteries, which had been identified as collaterals
on the pre-treatment DSA (Fig. 3).
EE occurred more often in patients treated under conscious
sedation compared to general anesthesia (n=8/20 (40.0 %) vs
n=5/37 (13.5 %); P=0.044). EEs were less frequently ob-
served with distal access catheter technique use compared to
non-use (n=1/15 (6.7 %) vs n=12/42 (28.6 %)), but the dif-
ference was not significant (P=0.150). Stroke etiologies were
similar in both groups (P=0.617) and so were thrombus
length on SWI (P=0.601) and duration from symptom onset
to start of DSA (P=0.488; Table 2).
In patients with a clinical follow-up at 3 months, favorable
clinical outcome (mRS score 0–2) was achieved in 7 of 12
patients (58.3 %) and 29 of 41 patients (70.7 %) with and
without EE, respectively (P=0.490). One of 12 patients
(8.3 %) with and 3 of 43 patients (7.0 %) without emboli died
within 3 months (P=1.000).
Discussion
Clinical outcome after mechanical thrombectomy is highly
variable despite high revascularization rates [1–12]. Clinical
outcome, among other factors, is device-dependent, with stent
retrievers showing higher rates of recanalization and favorable
outcome than devices that cause thrombus fragmentation [5,
10]. This was confirmed by the SWIFT and TREVO 2 studies
[5, 10]; however, for both MERCI and the stent retriever
groups, the rate of good clinical outcome was lower than in
old studies on intraarterial thrombolysis, despite that NIHSS is
comparable and treatment selection was less restrictive in
PROACT 2, MELT [9, 18], and the Swiss study [26], com-
paring intravenous (iv) and intraarterial (ia) thrombolysis
(Table 3). The risk of embolic complications is of particular
concern in mechanical thrombectomy, as emboli can impair
collateral blood supply to the affected territory, accelerate pen-
umbral tissue loss, and cause additional ischemic lesions [19].
This is in accordance with a study demonstrating that the
presence of multiple thrombi before initiation of thrombolytic
therapy predicts worse outcome [22].
In the present study, we analyzed a series of patients under-
going protected stent retriever thrombectomy. Mechanical
thrombectomy was performed in flow arrest and under aspi-
ration using a balloon-mounted guiding catheter, a distal ac-
cess catheter, or both. Peri-interventional EEs following
thrombectomy were detected on SWI in 22.8 % of patients.
Fig. 3 The post-interventional SWI of this 76-year-old man with a stroke
of NIHSS 13 shows the EE in a parietal branch of the right MCA (a). As
demonstrated by the frozen lateral DSA projection, proximal stagnating
of contrast flow in the sylvian segment about 2 cm in front of the EE
(white ring) is compensated by retrograde flow in the suprasylvian
branches, which have been identified in the initial DSA as collaterals,
coming down from the anterior cerebral artery (b, black arrows). The
resulting minimal blush as well as the visualization of all arteries in the
AP projection may have been the reason that the interventional team rated
the final DSA series as TICI 3 in this patient. The stagnating flow in the
distal temporo-occipital branches is not related to EE but to still active
collaterals from the vertebrobasilar system
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Emboli were mostly solitary and showed a similar signal in-
tensity as the primary occluding thrombus. Emboli were ex-
clusively located in the vascular territory distal to the primary
arterial occlusion and therefore resulted most likely from frag-
mentation during thrombus mobilization.
On DWI, new ischemic lesions associated with EE were
found in three of 16 EEs. Even in retrospect, stagnation or
reversed flow in the vicinity of the EE in addition with a subtle
decrease in parenchymal blush could be presumed in four
patients only (Figs. 2 and 3). These subtle signs of local flow
restriction were visible when the images of the lateral projec-
tion of the DSA were evaluated dynamically, but not on the
AP view or in the 3D rotation angiography.
The small size of the EE may be one reason for the restrict-
ed visibility in the DSA. In contrast to EEs in new vascular
territories, which are normally well visible even on frozen
DSA images (1–3), downstream EEs migrate only to the wa-
tershed zone, where the antegrade flow and pressure are in
balance with the reversed flow of the collaterals. Therefore,
comparable with embolic basilar artery occlusion, down-
stream iatrogenic EEs are not fixed and compressed in an
artery with a diameter smaller than the EE, which can result
in small oscillations of the thrombus and discrete bloodflow
around the EE. This may be another reason, why it is difficult
to detect downstream EE as a clear-cut branch occlusion.
Considering the sensitivity of DSA to motion artifacts, it is
Table 1 Details of patients with emboli on post-interventional susceptibility-weighted imaging
Case Age/sex Occlusion site Baseline
NIHSS
score
Stroke
etiology
Reperfusion
grade
(TICI)
Number
of emboli
Location of emboli
(outside/inside infarct)
Emboli
associated
with new
ischemia
mRS score at
3 months
1 67/M ICA/M2 11 Large artery disease 3 1 Outside No 3
2 62/M M1 7 Cardioembolic 3 2 Outside No 1
3 72/M M1 5 Cardioembolic 3 1 Outside No 0
4 48/F M1 9 Unknown 3 1 Inside No 0
5 70/F M1 5 Cardioembolic 3 1 Outside No 1
6 75/F M1 21 Cardioembolic 3 1 Outside Yes 4
7 38/F M2 5 Other 3 1 Outside No 1
8 73/F M1 14 Unknown 3 1 Outside No Lost to
follow-up
9 68/F M1 23 Unknown 2b 1 Outside No 0
10 77/M M1 17 Large artery disease 2b 3 Inside No 3
11 76/M M2 13 Unknown 3 1 Inside Yes 1
12 83/M M1 21 Unknown 3 1 Outside Yes 3
13 79/F Distal ICA 14 Cardioembolic 2b 1 Inside No 6
NIHSS NIH Stroke Scale, TICI Thrombolysis in Cerebral Infarction, mRSmodified Rankin Scale,M1M1 segment of the MCA,M2M2 segment of the
MCA
Fig. 4 The DSA of the dominant vertebral artery in this 79-year-old
woman with occlusion of the internal carotid artery shows the
retrograde filling of the posterior parietal branches of the MCA (a). Due
to the still active collaterals from the vertebrobasilar system, not visible in
the selective DSA, the interventional team rated this as TICI 2b based on
the stagnating flow and diminished temporooccipital blush (b). Quality
control MR the next day found neither EE nor DWI lesions in this area
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not a surprise that indirect discrete signs of flow stagnation may
be obliterated and may be detected retrospectively only, after
post-processing of the DSA, including motion correction.
Currently, modified TICI is considered the optimal grading
system for the evaluation of endovascular recanalization [27].
In view of our finding that the majority of peri-procedural EEs
are invisible in DSA, post-treatment SWI may be a valuable
complement to DSA for assessment of the success and safety
of endovascular procedures.
Peri-interventional emboli, as detected on DSA, were found in
up to 48%of patients treatedwith the Penumbra system [28], and
an analysis of the histological structure of clots extracted by the
Merci retrieval system reported that in 64 %, thrombi were re-
trieved in multiple fragments [29]. In the MR CLEAN study
using various types of intraarterial techniques, iatrogenic emboli-
zation to primarily non-affected vascular territories was observed
in 8.6 % of patients and 5.6 % had clinical signs of a new ische-
mic stroke [1]. A blinded core lab found nine new emboli (6 %),
two of them in primarily non-occluded arteries (1.4 %), in a
multicenter study, using the Solitaire stent retriever with balloon
protection in 74% of interventions [2]. In a studywithmandatory
use of balloon protection, two emboli were detected in 202 pa-
tients (1 %) by the corelab and no embolic event was observed in
the subgroup of 119 patients treated with iv thrombolysis in
addition to protected stent retriever thrombectomy [3]. The low
rate of embolization to primarily non-affected vascular territories,
serving as collaterals to the penumbral tissue [19], might contrib-
ute to the better clinical outcomes seen in the latter studies [2, 3]
compared to those using predominantly devices and techniques
that achieve recanalization through thrombus fragmentation [6, 7,
15–17] or stent retriever thrombectomy without mandatory
protection [1, 5, 10] (Table 3).
Modern CT [30] and MRI techniques [24] allow pre-
interventional visualization of thrombus length and shape, help-
ing the interventionist to deploy the stent retriever over the
whole thrombus length. In our study, retraction of the thrombus
was performed in flow arrest and simultaneous aspiration using
a balloon-mounted guiding catheter. In addition, in patients with
anatomically difficult access, a distal access catheter was used.
This might explain the fact that distal emboli were only detected
in the vascular territory distal to the primary occlusion and not in
adjacent territories (e.g., ACA territory). The tiny EEs seen
downstream to the primary occlusion site may have been caused
by shearing-off of small thrombus parts to perforating arteries
during thrombus mobilization, a phenomenon that could be ob-
served in animal models using radiopaque thrombi [20].
Creation of the iatrogenic EE during the passage of the occlusion
is unlikely, because we know that the microcatheter never
Table 2 Anterior circulation
stroke: clinical, procedural, and
outcome parameters in patients
with and without peri-
interventional embolic events
Patients with
emboli
(n=13, 22.8 %)
Patients without
emboli
(n=44, 77.2 %)
Intravenous thrombolysis, n (%) 6 (46.2) 21 (47.7)
Successful reperfusion (TICI 2b–3), n (%) 13 (100) 36 (81.8)
Interventional characteristics, n (%)
Distal access catheter use 1 (7.7) 14 (31.8)
Multimodal therapy 5 (38.5) 23 (52.3)
Thromboaspiration 3 (23.1) 15 (34.1)
Extracranial and intracranial stenting 1 (7.7) 9 (20.5)
Intraarterial thrombolysis 1 (7.7) 9 (20.5)
Anesthesia, n (%)
General anesthesia 5 (38.5) 32 (72.7)
Conscious sedation 8 (61.5) 12 (27.3)
Symptomatic ICH, n (%) 0 (0.0) 3 (6.8)
Asymptomatic ICH, n (%) 3 (23.1) 8 (18.2)
Favorable outcome (mRS score 0–2) at 3 months, n (%) 7/12 (58.3) 29/41 (70.7)
Dead at 3 months, n (%) 1/12 (8.3) 3/43 (7.0)
Stroke etiology, n (%)
Large artery disease 2 (15.4) 8 (18.2)
Cardioembolic 5 (38.5) 20 (45.5)
Other determined etiology 1 (7.7) 4 (9.1)
Unknown aetiology 5 (38.5) 12 (27.3)
Atrial fibrillation, n (%) 5/12 (41.7) 16/39 (41.0)
Thrombus length on pre-interventional SWI (mm), mean (SD) 13.4 (10.1) (n=12) 12.8 (6.1) (n=37)
TICI Thrombolysis in Cerebral Infarction, mRS modified Rankin Scale, ICH intracranial hemorrhage
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penetrates the thrombus itself but passes the site of occlusion
between the vessel wall and the thrombus [31]. In addition,
careful microcatheter contrast injection distal to the occlusion
is a mandatory part of our stroke protocol, to confirm that the
size of the artery is suitable to deploy the stent retriever.
However, we have never been able to detect distal EE, neither
primary fragmented thrombi, as discussed recently in a theoret-
ical framework [21], nor iatrogenic EE.
Interestingly, this assumption may be supported by a trend
for less frequent EE when distal access catheters were used
(6.7 vs 28.6 %), but the difference was not significant (P=
0.150). Distal access catheters may facilitate the mobilization
of thrombi by adding the suction power of the aspiration cath-
eter to the traction force of the stent retriever, reducing the risk
of distal embolization during thrombus mobilization. In addi-
tion, the distance the thrombus has to be retracted through the
vessel is minimized, thus protecting the origins of arterial
branches that have to be passed during retraction.
The rates of favorable clinical outcome at 3 months were
not significantly different in patients with and without emboli
(58.3 vs 70.7 %; P=0.490). This seems to be in contrast to a
recent study that demonstrated that primarily fragmented
thrombi detected before initiation of thrombolytic therapy pre-
dicted worse outcome [22]. This discrepancy could have three
Table 3 Trials on endovascular treatment of anterior circulation stroke: clinical outcome in relation to baseline NIHSS score and endovascular
techniques applied
Study designation Number of patients undergoing
endovascular treatment
Baseline NIHSS
score, median
Favorable outcome
(mRS score 0–2)
at 3 months (%)
Endovascular
techniques applied
PROACT II [18] 121 17 40 ia prourokinase
MELT [9] 57 14 49 ia urokinase
Mattle et al. [26] 55 17a 53 ia urokinase
Galimanis et al. [31] 623 15 49 ia urokinase, aspiration,
stent retriever (Solitaire)
Multi MERCI trial [7] 164 19 36 Distal Thrombectomy (Merci)
Penumbra trial [6] 125 18a 25 Fragmentation/aspiration
(Penumbra)
SWIFT [10]
- Merci 58 18 28 Merci
- Solitaire 55 17 37 Solitaire (protection not mandatory)
TREVO 2 [5]
- Merci 90 18 22 Merci
- TREVO 88 19 40 Stent retriever (Trevo, protection
not mandatory)
MR CLEAN [1] 233 17 33 ia alteplase or urokinase, thrombus
retraction, aspiration, wire
disruption, stent retriever
(protection not mandatory)
IMS III [15] 434 17 41 Merci, Penumbra, Solitaire
(protection not mandatory), ia tPA
MR RESCUE [16] 64 16 (penumbral),
19 (non-penumbral
19 Merci, Penumbra, ia tPA
SYNTHESIS [17] 181 13 42 ia tPA, wire disruption, Merci,
Penumbra, Trevo, Solitaire
(protection not mandatory)
Dávalos et al. [2] 141 18 55 Solitaire (protection in 74 %
of interventions)
STAR trial [3] 202 17 58 Solitaire (protection mandatory)
ESCAPE trial [11] 165 16 53 Stent retriever recommended
(protection recommended)
EXTEND-IA trial [12] 35 17 71 Solitaire (protection mandatory)
REVASCAT [13] 103 17 44 Solitaire (protection not mandatory)
SWIFT prime [14] 98 17 60 Solitaire (protection mandatory)
ia intraarterial, NIHSS NIH Stroke Scale, mRS modified Rankin Scale
aMean
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reasons. First is that the number of patients with EE was too
small to show a significant difference. Second is that emboli
seen in our patient cohort were smaller than those in patients
with multiple thrombi before initiation of thrombolytic thera-
py [22]. In fact, only a minority of patients with EE showed
signs of tissue damage on DWI that could be attributed to
iatrogenic emboli. Last, the reason for the good clinical out-
come might be that no embolization to primarily non-affected
vascular territories occurred in patients with and without EE.
EEs have been found in a significantly higher percentage of
patients who underwent thrombectomy with conscious seda-
tion compared to patients treated with general anesthesia (40.0
vs 13.5 %; P=0.044). Unlike in general anesthesia, patients
with conscious sedation often move during the potentially
painful mobilization and retraction of the thrombus. Patient
movement might increase the risk of embolization, as it im-
pairs the quality of flow arrest and aspiration and mobilization
and retraction of the thrombus cannot be performed in a slow
and controlled fashion.
Our study has some limitations. First, not all EEs seen on
post-interventional SWI may have actually been related to
mechanical thrombectomy itself. New EEs could also be re-
lated to ongoing embolization from the primary embolic
source of the stroke or migration of thrombus remnants still
in place after thrombectomy. Second, the extensive artifacts
on SWI generated in the proximity of the skull base limit the
evaluation of the adjacent brain parenchyma, the vessels of the
posterior circulation, and the intracranial parts of the ICA.
Third, the distinction between embolus and hemorrhagic
transformation on SWI can be equivocal if the hypointensities
are located inside infarcted parenchyma. In such patients, only
isolated dot-like lesions were counted as emboli. However, the
majority of EEs were detected outside the infarcted territory
(n=9/13), making hemorrhagic transformation very unlikely.
Moreover, most EEs were of a slightly elongated shape
(Figs. 1, 2, and 3), due to the orientation of the thrombotic
material in the vessels. This helps to distinguish them from
cerebral microbleeds, usually presenting spherical in SWI
[32]. Quantitative susceptibility mapping (QSM) was per-
formed in a few of our patients only but may improve the
specificity of this new source of MR image contrast [33, 34].
Fourth, in many patients, the time span between
endovascular treatment and post-treatment imaging was quite
long. Mean size of the EE as measured on SWI was 5.2 mm.
However, the length of the thrombi may be shorter due to the
blooming effect [24] and oscillations of the downstream EE,
as described above. It cannot be excluded that ongoing throm-
bolysis may have caused the disappearance of some peri-
interventional EEs on post-treatment SWI. However, EEs
were equally distributed in patients treated primarily by
endovascular approach (23 %; seven EEs in 30 patients) and
the bridging group (22 %; six EEs in 27 patients), but the
number of patients is too small, to draw any conclusion.
Fifth, the field strength of the MRI scanners was not stan-
dardized across patients because we use several scanners in
clinical stroke imaging. Previous studies have shown that the
detectability of cerebral microbleeds on SWI improves with
increasing field strength [35]. Thus, the detection rate of EE is
most likely influenced by field strength as well. Nonetheless,
this phenomenon did not seem to have a major impact on our
study results, as six EEs (46.2 %) were detected on SWI ac-
quired with a 1.5-T and seven EEs (53.8 %) with a 3-T MRI.
Conclusions
This study demonstrates that SWI can be applied to detect
peri-interventional microemboli that are only partially seen
on follow-up DWI or DSA, currently the standard techniques
used for the detection of EE related to endovascular proce-
dures [1, 15, 16, 21]. The possibility to non-invasively visu-
alize iatrogenic EE makes SWI an interesting tool to evaluate
the quality of thrombectomy techniques and to improve in-
struments and techniques for endovascular stroke treatment.
This quality control is needed to evaluate the safety of
thrombectomy devices and techniques before they are used
in patients for clinical routine as well as in clinical trials.
SWI before and after endovascular, image-guided,
microneurosurgical stroke therapy confirms that stent retriever
combined with emboli protection techniques may prevent iat-
rogenic embolization to primarily non-affected vascular terri-
tories during the retraction of the thrombus, however, not
downstream emboli during its mobilization.
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